4D Molecular Therapeutics, Inc. (FDMT)
10.80
-1.05
(-8.86%)
USD |
NASDAQ |
Oct 23, 16:00
10.78
-0.02
(-0.23%)
After-Hours: 20:00
4D Molecular Therapeutics Market Cap : 596.31M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 596.31M |
| October 22, 2026 | 654.29M |
| October 21, 2026 | 696.80M |
| October 20, 2026 | 723.30M |
| October 19, 2026 | 678.58M |
| October 16, 2026 | 670.30M |
| October 15, 2026 | 710.61M |
| October 14, 2026 | 673.61M |
| October 13, 2026 | 682.45M |
| October 12, 2026 | 717.78M |
| October 09, 2026 | 736.00M |
| October 08, 2026 | 701.22M |
| October 07, 2026 | 695.15M |
| October 06, 2026 | 693.49M |
| October 05, 2026 | 713.37M |
| October 02, 2026 | 754.78M |
| October 01, 2026 | 764.16M |
| September 30, 2026 | 790.11M |
| September 29, 2026 | 800.05M |
| September 28, 2026 | 803.92M |
| September 25, 2026 | 798.95M |
| September 24, 2026 | 812.20M |
| September 23, 2026 | 828.21M |
| September 22, 2026 | 876.80M |
| September 21, 2026 | 841.46M |
| Date | Value |
|---|---|
| September 18, 2026 | 840.36M |
| September 17, 2026 | 810.54M |
| September 16, 2026 | 759.75M |
| September 15, 2026 | 752.57M |
| September 14, 2026 | 759.75M |
| September 11, 2026 | 727.17M |
| September 10, 2026 | 744.84M |
| September 09, 2026 | 782.94M |
| September 08, 2026 | 807.78M |
| September 04, 2026 | 826.56M |
| September 03, 2026 | 811.65M |
| September 02, 2026 | 824.90M |
| September 01, 2026 | 792.32M |
| August 31, 2026 | 779.07M |
| August 28, 2026 | 809.99M |
| August 27, 2026 | 823.24M |
| August 26, 2026 | 859.13M |
| August 25, 2026 | 867.97M |
| August 24, 2026 | 849.74M |
| August 21, 2026 | 874.04M |
| August 20, 2026 | 888.95M |
| August 19, 2026 | 925.39M |
| August 18, 2026 | 812.75M |
| August 17, 2026 | 803.09M |
| August 14, 2026 | 673.06M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 269.76M |
| Amgen, Inc. | 237.46B |
| Anika Therapeutics, Inc. | 286.66M |
| BioCryst Pharmaceuticals, Inc. | 1.953B |
| Imunon, Inc. | 5.762M |
Market Cap Related Metrics
| PS Ratio | 7.397 |
| Price to Book Value | 1.463 |
| Price | 10.80 |
| Earnings Yield | -25.23% |